Home
Who we are
Apollo
Partnering with us
- OEM Partners
- AI Platforms and Distributors
Resources
Contact us

Local Gamma Augmentation for Ischemic Stroke Lesion Segmentation on MRI

Source: UNIVERSITY OF COPENHAGEN

Schedule a demo to discover more
about Apollo and its features

Ready to see Apollo in action? Book a demo today to experience how our solutions can be tailored to meet the unique needs of your healthcare setting.

Cerebriu A/S
Danneskiold-Samsøes Allé 41
1434 Copenhagen, Denmark
CVR : 39739569

X
LinkedIn
YouTube

Mission & Partners

Conference Contribution

Webinar & Pitch

ESNR 2025

09/17/2025
– 09/21/2025

WNRS 2025

10/23/2025
– 10/26/2025

Smart Priority, Smart Protocol, Smart Reading are features of Cerebriu Apollo 2.1.2 (2-2031-5). Cerebriu Apollo is regulated as a medical device in the EU. This product conforms to Medical Device Directive 93/42/EEC and is covered by MDR 2017/745 Article 120. For investigation use only in the US.